Disease relevance of Intracranial Arteriovenous Malformations

• Hemodynamic simulation study of cerebral arteriovenous malformations. Part 2. Effects of impaired autoregulation and induced hypotension [1].
• As part of a series of patients with cerebral arteriovenous malformations and epilepsy, we identified two patients with probable secondary epileptogenesis in the mesiotemporal regions, ipsilateral but anatomically distant from an arteriovenous malformation causing seizures [2].
• From November 1976 to September 1979, 46 patients with intracranial arteriovenous malformations or fistulas participated in a clinical study using isobutyl 2-cyanoacrylate (IBCA), with tantalum, for palliative or preoperative occlusion of the blood supply to the abnormalities [3].
• Pulmonary embolization and infarction. An iatrogenic complication of transcatheter embolization of a cerebral arteriovenous malformation with polyvinyl alcohol sponge [4].
• The development of digoxin toxicity in the context of accepted therapeutic dosing to treat heart failure due to a cerebral arteriovenous malformation is discussed [5].

High impact information on Intracranial Arteriovenous Malformations

• We examined 17 intracranial arteriovenous malformations that were resected after treatment by embolization using bucrylate (isobutyl-2-cyanoacrylate) [6].
• The effect of intravenous infusion of adenosine on CBF was studied in seven patients with cerebral arteriovenous malformation [7].
• A patient with maculopapular reactions to iopamidol needed to undergo angiography for a cerebral arteriovenous malformation [8].
• Intracranial arteriovenous malformations: real-time auto-triggered elliptic centric-ordered 3D gadolinium-enhanced MR angiography--initial assessment [9].
• This is a report of the rupture of an intracranial arteriovenous malformation complicating the use of tissue plasminogen activator therapy [10].

Chemical compound and disease context of Intracranial Arteriovenous Malformations

• Radiosurgery for cerebral arteriovenous malformations: assessment of early phase magnetic resonance imaging and significance of gadolinium-DTPA enhancement [11].
• Preoperative embolization of cerebral arteriovenous malformations with polyvinyl alcohol particles: experience in 51 adults [12].
• PURPOSE: To describe our experience with the use of Amytal injected through a superselective catheter prior to planned embolization of cerebral arteriovenous malformations [13].
• A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience [14].
• A nonadhesive liquid embolic agent composed of ethylene vinyl alcohol copolymer and ethanol mixture for the treatment of cerebral arteriovenous malformations: experimental study [15].

Gene context of Intracranial Arteriovenous Malformations

• Hypoxia inducible factor-1alpha and expression of vascular endothelial growth factor and its receptors in cerebral arteriovenous malformations [16].
• Cerebral arteriovenous malformations were more common in patients with HHT1, but spinal arteriovenous malformations were seen only in patients with HHT2 [17].
• We reported a patient with Leber's hereditary optic neuropathy (LHON) with an intracranial arteriovenous malformation (AVM) [18].
• Specific repression of the preproendothelin-1 gene in intracranial arteriovenous malformations [19].
• Autosomal dominant polycystic kidney disease in the neonatal period: association with a cerebral arteriovenous malformation [20].

Analytical, diagnostic and therapeutic context of Intracranial Arteriovenous Malformations

• OBJECTIVE: In an animal model, we tested the hypothesis that intracerebral, extracellular norepinephrine (NE) influences cerebral blood flow (CBF) in the presence of cerebral arteriovenous malformations (AVMs) [21].
• Basic fibroblast growth factor impregnated hydrogel microspheres for embolization of cerebral arteriovenous malformations [22].
• Preembolization functional evaluation in supratentorial cerebral arteriovenous malformations with superselective intraarterial injection of thiopental sodium solution [23].

References